# A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children

> **NCT00344305** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 200 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Trivalent influenza virus vaccine live, intranasal

## Key facts

- **NCT ID:** NCT00344305
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-01
- **Primary completion:** 2006-07-01
- **Final completion:** 2006-12-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344305, "A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00344305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*